U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ICRUCUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
IMC 18F1
Preferred Name English
Icrucumab [WHO-DD]
Common Name English
IMC-18F1
Code English
icrucumab [INN]
Common Name English
ICRUCUMAB [USAN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN TYPE VEGFR-1 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR) (HUMAN MONOCLONAL 18F1 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 18F1 .KAPPA.-CHAIN, DIMER
Common Name English
IMC18F1
Code English
Classification Tree Code System Code
NCI_THESAURUS C93170
Created by admin on Mon Mar 31 19:56:26 GMT 2025 , Edited by admin on Mon Mar 31 19:56:26 GMT 2025
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 19:56:26 GMT 2025 , Edited by admin on Mon Mar 31 19:56:26 GMT 2025
Code System Code Type Description
SMS_ID
100000175058
Created by admin on Mon Mar 31 19:56:26 GMT 2025 , Edited by admin on Mon Mar 31 19:56:26 GMT 2025
PRIMARY
ChEMBL
CHEMBL1743030
Created by admin on Mon Mar 31 19:56:26 GMT 2025 , Edited by admin on Mon Mar 31 19:56:26 GMT 2025
PRIMARY
INN
9370
Created by admin on Mon Mar 31 19:56:26 GMT 2025 , Edited by admin on Mon Mar 31 19:56:26 GMT 2025
PRIMARY
FDA UNII
T7H0B1R64U
Created by admin on Mon Mar 31 19:56:26 GMT 2025 , Edited by admin on Mon Mar 31 19:56:26 GMT 2025
PRIMARY
CAS
1024603-92-6
Created by admin on Mon Mar 31 19:56:26 GMT 2025 , Edited by admin on Mon Mar 31 19:56:26 GMT 2025
PRIMARY
WIKIPEDIA
ICRUCUMAB
Created by admin on Mon Mar 31 19:56:26 GMT 2025 , Edited by admin on Mon Mar 31 19:56:26 GMT 2025
PRIMARY
DRUG BANK
DB14824
Created by admin on Mon Mar 31 19:56:26 GMT 2025 , Edited by admin on Mon Mar 31 19:56:26 GMT 2025
PRIMARY
USAN
WW-103
Created by admin on Mon Mar 31 19:56:26 GMT 2025 , Edited by admin on Mon Mar 31 19:56:26 GMT 2025
PRIMARY
NCI_THESAURUS
C79808
Created by admin on Mon Mar 31 19:56:26 GMT 2025 , Edited by admin on Mon Mar 31 19:56:26 GMT 2025
PRIMARY
ACTIVE MOIETY
ICRUCUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966